Download PDF
Thromb Haemost 1987; 57(03): 294-297
DOI: 10.1055/s-0038-1651119
Original Article
Schattauer GmbH Stuttgart

Platelet Release in Hemophilia

Hamid Al-Mondhiry
The Division of Hematology, Department of Medicine, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, USA
› Author Affiliations
Further Information

Publication History

Received 27 January 1987

Accepted 17 February 1987

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Platelet function abnormalities have been described in some patients with hemophilia. This study reports measurements of plasma β-thromboglobulin (BTG) and platelet factor 4 (PF4), sensitive and specific markers of platelet α-granule release in 72 hemophiliacs. Patients were studied on multiple occasions depending on their clinical condition and the treatment given. Stable patients without recent bleeding showed significantly elevated BTG levels: 29.72 ± 12.77 ng/ml, control 23.22 ± 8.22, p = 0.006. This appears to be independent of the presence of liver disease, human immune deficiency virus infection (HIV) and the acquired immune deficiency syndrome (AIDS). The increased BTG level seems to correlate with the severity of the disease as reflected by the frequency of bleeding and the quantity of factor concentrate used but not with plasma factor VIII or IX procoagulant activity. Patients who have experienced recent bleeding showed a marked rise in BTG level (77.26 ± 51.37 ng/ml, p = 0.0002), indicating enhanced in vivo platelet activation. These observations suggest that enhanced platelet release in hemophilia most likely reflects sustained activation of hemostasis secondary to frequent bleeding characteristic of the severe form of the disease.

Keywords

Platelet release - Hemophilia
 

  • References

  • 1 Hope W, Martin TJ, Chesterman CN, Morgan FJ. Human β-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells. Nature 1979; 282: 210-212
    CrossrefPubMedGoogle Scholar
  • 2 Shattil SJ, Bennett JS. Platelets and their membrane in hemostasis: physiology and pathology. Ann Intern Med 1980; 94: 108-118
    PubMedGoogle Scholar
  • 3 Bolton AE, Ludlam CA, Pepper DS, Moore S, Cash JD. A radioimmunoassay for platelet factor 4. Thromb Res 1976; 8: 51-58
    CrossrefPubMedGoogle Scholar
  • 4 Bolton AE, Ludlam CA, Moore S, Pepper DS, Cash JD. Three approaches to the radioimmunoassay of β-thromboglobulin. Brit J Haematol 1976; 33: 233-238
    CrossrefPubMedGoogle Scholar
  • 5 Kaplan KL, Nossel HL, Drillings M, Lesznik G. Radioimmunoassay of platelet factor 4 and β-thromboglobulin: Development and application of studies of platelet release in relation to fibrinopeptide A generation. Brit J Haematol 1978; 39: 129-146
    CrossrefPubMedGoogle Scholar
  • 6 Smith RC, Duncanson J, Ruckley CV, Webber RG, Allan NC, Dawes J, Bolton AE, Hunter WM, Pepper DS, Cash JD. β-thromboglobulin and deep vein thrombosis. Thromb Haemostas 1978; 39: 338-345
    PubMedGoogle Scholar
  • 7 Weiss HJ, Witte L, Kaplan KL, Lager BA, Chernoff A, Nossel HL, Goodman DS, Baumgartner HR. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in α-granules, platelet factor 4, β-thromboglobulin, and platelet growth factor. Blood 1979; 54: 1296-1319
    PubMedGoogle Scholar
  • 8 Cella G, Zahavi J, DeHaas HA, Kakkar VV. β-thromboglobulin, platelet production time and platelet function in vascular disease. Brit J Haematol 1979; 43: 127-136
    CrossrefPubMedGoogle Scholar
  • 9 Preston FE, Ward JD, Marcola BH, Porter NR, Timperley WR. Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978; 1: 238-239
    PubMedGoogle Scholar
  • 10 Nichols AB, Owen J, Kaplan KL, Sciacca RR, Cannon PJ, Nossel HL. Fibrinopeptide A. Platelet factor 4 and β-thromboglobulin levels in coronary heart disease. Blood 1982; 60: 650-654
    PubMedGoogle Scholar
  • 11 Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet α-granule release in vivo. Blood 1981; 58: 607-618
    PubMedGoogle Scholar
  • 12 White GC, Marouf AA. Platelet factor 4 levels in patients with coronary artery disease. J Lab Clin Med 1981; 97: 369-378
    PubMedGoogle Scholar
  • 13 Ireland H, Lane DA, Wolff S, Foadi M. In vivo platelet release in myeloproliferative disorders. Thrombos Haemostas 1982; 48: 41-45
    PubMedGoogle Scholar
  • 14 Parbtani A, Frampton G, Cameron JS. Measurement of platelet release substances in glomerulonephritis: a comparison of betathromboglobulin (BTG), platelet factor 4 (PF4) and serotonin assays. Thrombosis Res 1980; 19: 177-189
    CrossrefPubMedGoogle Scholar
  • 15 DeBoer AC, Turpie A GG, Butt RW, Duke RJ, Bloch RF, Genton E. Plasma betathromboglobulin and serum fragment E in acute partial stroke. Brit J Haematol 1982; 50: 327-334
    CrossrefPubMedGoogle Scholar
  • 16 Al-Mondhiry H. Beta-thromboglobulin and platelet factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy. Am J Hematol 1983; 14: 105-111
    CrossrefPubMedGoogle Scholar
  • 17 Levine SP, Lindenfeld J, Ellis JB, Raymond NJ, Krentz IS. Increased plasma concentrations of platelet factor 4 in coronary artery disease. Circulation 1981; 46: 626-632
    PubMedGoogle Scholar
  • 18 Douglas JT, Shah J, Lowe G DO, Belch J JF, Forbes CD, Prentice C RM. Plasma fibrinopeptide A and beta-thromboglobulin in preeclampsia and pregnancy hypertension. Thromb Hemostas 1979; 47: 54-55
    PubMedGoogle Scholar
  • 19 Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G. Circulating platelet products in unstable angina pectoris. Circulation 1981; 63: 300-306
    CrossrefPubMedGoogle Scholar
  • 20 Al-Mondhiry H, Pierce WS, Pennock JL. Platelet release in coronary heart disease: Effect of antiplatelet drugs and coronary artery bypass surgery. J Lab Clin Med 1985; 105: 397-402
    PubMedGoogle Scholar
  • 21 Borok Z, Weitz J, Owen J, Auerbach M, Nossel HL. Fibrinogen proteolysis and platelet a-granule release in pre-eclampsia/eclampsia. Blood 1984; 63: 525-531
    PubMedGoogle Scholar
  • 22 Borchgrevink CF. Platelet adhesion invivo in patients with bleeding disorders. Act Med Scand 1961; 170: 231-243
    PubMedGoogle Scholar
  • 23 Sixma JJ, van den Berg A. The hemostatic plug in hemophilia A. A morphological study of hemostatic plug formation in bleeding time skin wounds of patients with severe hemophilia A. Brit J Haematol 1984; 58: 741-753
    CrossrefPubMedGoogle Scholar
  • 24 Hathaway WE, Mahosandana C, Clarke S, Humbert JR. Paradoxical bleeding in intensively transfused hemophiliacs. Transfusion 1973; 13: 6-12
    CrossrefPubMedGoogle Scholar
  • 25 Buchanan GR, Holtkamp CA. Prolonged bleeding time in children and young adults with hemophilia. Pediatrics 1980; 66: 951-955
    PubMedGoogle Scholar
  • 26 Eyster ME, Gordon RA, Ballard JO. The bleeding time is longer than normal in hemophilia. Blood 1981; 58: 719-723
    PubMedGoogle Scholar
  • 27 Update: Acquired immune deficiency syndrome (AIDS) among patients with hemophilia in the United States. MMWR 1984; 33: 589-591
    PubMedGoogle Scholar
  • 28 Eyster ME, Goedert JJ, Sarangadharan MG, Weiss S HD, Gallo RC, Blattner WA. Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA 1985; 253: 2219-2223
    CrossrefPubMedGoogle Scholar
  • 29 Goedert JJ, Bigger RJ, Weiss SH, Eyster ME, Melbye M, Wilson S, Ginzburg HM, Grossman RJ, DiGioia RA, Sanchez WC, Giron JA, Ebbesen P, Gallo RC, Blattner WA. Three year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science 1986; 231: 992-995
    CrossrefPubMedGoogle Scholar
  • 30 Zar J HG. Binomial distribution. In Biostatistical Analysis. Englewood Cliffs NJ: 1974. Prentice Hall: p. 292
    Google Scholar
  • 31 Zazatchkine MD, Sultan Y, Burton-Kee EJ, Mowbray JF. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with hemophilia A. Clin Exp Immunol 1980; 39: 315-320
    PubMedGoogle Scholar
  • 32 Poskitt TR, Poskitt P KF, Bean CA, Arkel YS. Immune complexes in hemophilia. Am J Hematol 1981; 11: 147-152
    CrossrefPubMedGoogle Scholar
  • 33 Goodnight SH, Britell CW, Wuepper KD, Osterud B. Circulating factor IX antigen-inhibitor complexes in hemophilia B following infusion of a factor IX concentrate. Blood 1979; 53: 93-103
    PubMedGoogle Scholar
  • 34 Verroust F, Adam C, Kourilsky O, Allain JP, Verroust P. Circulating immune complexes and complement levels in hemophiliac children. J Clin Lab Immunol 1981; 6: 127-130
    PubMedGoogle Scholar
  • 35 McVerry BA, Voke J, Mohammed I, Dormandy KM, Holborow EJ. Immune complexes and abnormal liver function in hemophilia. J Clin Pathol 1977; 30: 1142-1146
    CrossrefPubMedGoogle Scholar
  • 36 Lambert PH. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand disease. Transfusion 1984; 24: 24-32
    PubMedGoogle Scholar
  • 37 Henser P, Spiegelberg HL. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subgroups. J Clin Invest 1973; 52: 1282-1288
    CrossrefPubMedGoogle Scholar
  • 38 Clark WF, Tevaarwerk G JM, Bandali K, Lindsay RM, Linton AL. Platelet aggregation and release associated with immune complex formation in pig plasma. J Lab Clin Med 1980; 96: 654-665
    PubMedGoogle Scholar
  • 39 Dawes J, Smith RC, Pepper DS. The release, distribution and clearance of human beta-thromboglobulin and platelet factor 4. Thrombo Res 1978; 12: 851-861
    CrossrefPubMedGoogle Scholar
  • 40 Kaplan K, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
    PubMedGoogle Scholar
  • 41 Ludlam CA. Evidence for the platelet specificity of -thromboglobulin and studies on its plasma concentration in healthy individuals. Brit J Haematol 1979; 41: 271-278
    CrossrefPubMedGoogle Scholar
  • 42 Zahavi J, Kakkar VV. β-thromboglobulin - a specific marker of in vivo platelet release reaction. Thromb Haemostas 1980; 44: 23-29
    PubMedGoogle Scholar